Cell & Gene Therapy Drug Delivery Devices Market Projected to grow at 14% CAGR By 2028 | Amgen Inc, Pfizer Inc, Novartis AG

This comprehensive Cell & Gene Therapy Drug Delivery Devices Market report by “MarkNtel Advisors: Leading Market research Company” offers valuable insights into the current and future market landscape, providing clarity on potential challenges and strategies for optimal brand positioning. It features detailed market segmentation, in-depth analysis of key market players, emerging trends in consumer behavior and supply chain dynamics, and opportunities in new geographical markets. With the insights from this report, you can manage your marketing strategies for goods and services more effectively.

“According to recent market analysis report, the Global Cell & Gene Therapy Drug Delivery Devices Market is expected to grow at a CAGR of 14% during the forecast period of 2023 to 2028.”

 “In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download Sample PDF Copy of this Report: - https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Driving Force Behind the Growth of the Cell & Gene Therapy Drug Delivery Devices Market through 2028

• Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
• Mounting prevalence of genetic disorders & chronic diseases
• An increasing number of FDA approvals for cell & gene therapies & their clinical trials

Market Segment Highlights:

By Product Type

• Sub-retinal Injection Cannula
• Extension Tube
• Intravenous Catheter
• Sterile Insulin Syringe
• Size 1.0 ML, 31-Gauge Needle
• Size 0.5 ML, 22-Gauge Needle
• Pre-Filled Syringe
• Size 1.0 ML, 22-26 Gauge Needle
• Size 4.0 ML, 22-26 Gauge Needle
• Infusion Bags
• Infusion Bags (Size 10 ML to 50 ML)
• Infusion Bags (Size 68 ML)
• Infusion Bags (Size 60 ML)
• Infusion Bags (Size Up to 65 ML)

By Technology

• Microchip Technology
• Nano-Technology
• Lipid Nanoparticles

By Commercialized Drugs

• Luxturna
• Kymriah
• Yescarta
• Zolgensma
• Provenge
• Strimvelis

Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2023. Luxturna (voretigene neparvovec-rzyl) is an Adeno-Associated Virus (AAV) vector-based gene therapy. It is for the treatment of patients with confirmed biallelic RPE65 mutation-associated Inherited Retinal Dystrophy (IRD), which causes vision loss and even complete blindness in some patients.

By End-User

• Pharmaceuticals & Biotechnology Company
• Academic & Research Institute
• Hospitals & Clinics

Cell & Gene Therapy Drug Delivery Devices Market Regional Outlook:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific.

Of all the regions, North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period. It owes to the mounting number of collaborations between several small & medium enterprises and numerous conglomerates to develop cost-effective & high-quality medicines that most people can afford

Explore the Full Report with Charts, Table of Contents, and List of Figures - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Cell & Gene Therapy Drug Delivery Devices Market Competition Analysis:

Some of the top Cell & Gene Therapy Drug Delivery Devices companies operating in the market are Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation.

Who We Are:

Our team entails professional analysts and researchers who intelligently utilize research techniques to procure detail-driven, unbiased, and reliable data encompassing the industry. We aim to nurture a result-oriented team to offer strategically-moving insights to our clients. 

Our fact-based reports allow the user to design their motives, funds, and strategies, with a higher focus on mitigating confusion and bringing forward a clear insight into the industry. It further allows the clients to identify the lucrative opportunities awaiting.

Insights offered by MarkNtel Advisors comprise in-depth information on regional & country-based trends emerging in the industry. The team studies & compiles the prospects, ensuring consistency in reports.

Our services are beyond offering research reports to the clients and further expand into addressing queries while incorporating with them for advice, development, & execution of strategies for exception growth.

Other Trending Reports:

• https://marknteladvisors.wixsite.com/home/post/cloud-gaming-market-by-latest-investment-leading-key-player-segment-and-development
• https://marknteladvisors.wixsite.com/home/post/generative-ai-market-insights-2030-unveiling-size-share-growth-and-trends
• https://marknteladvisors.wixsite.com/home/post/horticulture-lighting-market-size-share-and-development-insight-2024-discovering-opportunities
• https://marknteladvisors.wixsite.com/home/post/india-ice-cream-market-growth-trends-2024-30-exploring-industry-growth-demand-development-and-c
• https://marknteladvisors.wixsite.com/home/post/digital-camera-market-size-share-and-development-insight-2024-discovering-opportunities-latest

For Media Inquiries, Please Contact: 

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India